Octave Bioscience’s Comprehensive Care Platform provides a quantitative, objective measurement system designed to expand clinical insights in neurodegenerative disease, beginning with MS. It provides multiple layers of insight to provide a 360 degree view with a longitudinal perspective of disease progression. The first layer measures the patient’s underlying biology with blood based biomarkers that quantitatively and objectively assess inflammation and immune modulation. The second layer includes advanced measurement using improved MRI readings and interpretation to reveal more insights at the CNS layer, including the brain and spine. The final layer features real time tracking of symptoms via monitoring with mobile tools, sensors and wearables to identify changes in disease and alert care teams. All of this data is integrated into protocols, supported by decision support tools and feeds into a dashboard for ease of use. The Octave Platform allows individual and population views to facilitate better stratification and contextual interventions.

Biotechnology

Octave Bioscience

William Hagstrom

Reto Matter

Romy Sacks

Mary Aikins, RN, CCM

Ferhan Qureshi

Ati Ghoreyshi

Amanda Champion

Falguni Mehta

Mike Edgeworth

Maital Shemesh-Rasmussen

Melinda Thomas

Octave Bioscience's Founding Team includes Melinda Thomas and 1 others.

Founding Team

Board of Directors

CEO and Executive Team

Leadership Team

Founding Team

About

Team members

Other teams at Octave Bioscience

Board of Directors

CEO and Executive Team

Leadership Team